University of Vermont Cancer Center Member Profile
Jessica Cintolo-Gonzalez, MD
Chair, UVM Cancer Center Commission on Cancer Committee
Associate Professor, Surgical Oncology
Associate Member
Cancer Population Science (CPS)
Academic Interests
Dr. Cintolo Gonzalez’s research focus has primarily been in melanoma. She has performed retrospective analysis of UVM’s management of locoregional melanoma patients and also a prospective study on screening practices and impact on stage of presentation. Dr. Cintolo Gonzalez started the intralesional therapy program with T-VEC and is researching factors associated with response to this treatment as well as strategies for determining continuation or discontinuation of this treatment. She has an IIT assessing accuracy of ctDNA in determining disease status among melanoma patients with a variety of clinical presentations and am working on studies to assess how best to incorporate ctDNA into clinical practice for melanoma patients. She is the local co-PI on a neoadjuvant trial in melanoma and have other clinical trials pending in melanoma. She started UVM’s peritoneal surface malignancy program and is working to bring clinical trials for that group of patients. Dr. Cintolo Gonzalez is also involved in the breast oncology transdisciplinary team and have been the local PI for the COMET trial for DCIS. Her clinical practice and multidiscplinary clinical collaboration also includes sarcoma and endocrine oncology.
Dr. Cintolo Gonzalez’s research focus has primarily been in melanoma. She has performed retrospective analysis of UVM’s management of locoregional melanoma patients and also a prospective study on screening practices and impact on stage of presentation. Dr. Cintolo Gonzalez started the intralesional therapy program with T-VEC and is researching factors associated with response to this treatment as well as strategies for determining continuation or discontinuation of this treatment. She has an IIT assessing accuracy of ctDNA in determining disease status among melanoma patients with a variety of clinical presentations and am working on studies to assess how best to incorporate ctDNA into clinical practice for melanoma patients. She is the local co-PI on a neoadjuvant trial in melanoma and have other clinical trials pending in melanoma. She started UVM’s peritoneal surface malignancy program and is working to bring clinical trials for that group of patients. Dr. Cintolo Gonzalez is also involved in the breast oncology transdisciplinary team and have been the local PI for the COMET trial for DCIS. Her clinical practice and multidiscplinary clinical collaboration also includes sarcoma and endocrine oncology.